簡易檢索 / 詳目顯示

研究生: 戴富源
Fu-yuan Tai
論文名稱: 製備與評估已脱細胞的細胞外基質懸浮液並研究其對傷口癒合的影響
Preparation and Characterization of Decellularized ECM suspension and Its Effect on Wound Healing
指導教授: 高震宇
Chen-Yu Kao
口試委員: 羅俊民
Chun-Min Lo
蔡協致
Hsieh-Chih Tsai
學位類別: 碩士
Master
系所名稱: 應用科技學院 - 醫學工程研究所
Graduate Institute of Biomedical Engineering
論文出版年: 2020
畢業學年度: 108
語文別: 英文
論文頁數: 86
中文關鍵詞: 細胞外基質組織工程脫細胞化生物相容性再生醫學
外文關鍵詞: Extracellular matrix, Tissue engineering, Decellularization, Biocompatibility, Regenerative medicine
相關次數: 點閱:627下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報

細胞外基質(ECM)由結構和功能大分子的複雜混合物組成,在組織和器官形態以及維持細胞和組織結構功能中起到重要的作用。而細胞外基質在生長,發育和傷口修復過程中扮演重要的角色,其自身的動態成分可充當訊號分子的儲存庫,並介導其他來源的訊號使細胞遷移、增殖及分化。在天然生物醫學材料中,細胞外基質來源於動物組織,將源自動物組織的細胞外基質植入生物體內後,它可以釋放信號來調節動態細胞行為(例如增殖,存活,粘附和遷移)的能力,並影響細胞的快速生長以促進傷口再生。但是,在提取ECM的過程中我們必須使組織脫細胞,從組織中去除細胞以避免宿主組織排斥植入的ECM支架。從組織或器官中去除細胞會留下構成ECM的結構蛋白和功能蛋白的複雜混合物。
本研究描述了一種結合物理和化學處理的脫細胞方法。
第一階段,我們通過化學處理使膀胱組織脫細胞,將其凍乾粉末化,並且測定化學殘留以及膠原蛋白濃度的含量。第二階段為將萃取之細胞外基質製備為ECM懸浮液。第三階段進行體外細胞分析,利用ECIS及細胞劃痕試驗評估細胞外基質於對傷口癒合的作用與反應、生物相容性。
研究結果顯示,該實驗成功地從組織中去除了細胞,並且萃取出每毫克含有0.6mg之細胞外基質,並且無化學殘留的跡象。儘管在DNA分析中脫細胞後ECM的DNA含量大於50 ng/mg,可能有必要改進脫細胞方法以避免動物實驗中的排斥效應。在體外細胞試驗中,無論是ECIS測試還是傷口癒合試驗,HaCaT在較高濃度的細胞外基質懸浮液當中,表現出細胞附著電極的速率和細胞遷移速率明顯增加,儘管細胞外基質懸浮液的濃度高於膠原蛋白,但由於目前膠原蛋白相當昂貴,使用我們提取的細胞外基質是一種經濟的解決方案,並且可以達到與膠原蛋白相同的效果。
經由一系列實驗,脫細胞的ECM已經證明了它們作為支架誘導傷口癒合機制的潛力。未來的研究應進一步改良脫細胞方案,以使DNA小於50 ng/mg,以防止可能在動物實驗中發生的排斥反應。

關鍵字:細胞外基質、組織工程、脫細胞化、生物相容性、再生醫學


The extracellular matrix (ECM) consists of a complex mixture of structural and functional macromolecules and serves an important role in tissue and organ morphogenesis and in the maintenance of cell and tissue structure and function. The extracellular matrix evolves an important role in the growth, development, and wound repair processes. Its own dynamic composition acts as a reservoir for soluble signaling molecules and mediates signals from other sources to migrating, proliferating, and differentiating cells. In natural biomedical materials, the extracellular matrix derived from animal tissues is implanted in living organisms, it can release signals to abilities to regulate dynamic cellular behaviors, such as proliferation, survival, adhesion and migration, to influence rapid growth of the cells and to promote wound regeneration. To avoid the host tissue's rejection of the implanted ECM scaffold, we must remove cells from the ECM scaffold by a series of decellularization process. The complex mixture of structural and functional proteins of the ECM were maintains after the decellularization process and can be used for many biomedical applications.
In this study, we described a decellularization method that combines physical and chemical treatments.
In the first step of this study, bladder tissue was decellularized by chemical and physical treatments, lyophilized and powdered, and the contents of chemical residues and collagen concentration were determined. The second step was to prepare the extracted extracellular matrix as an ECM suspension. In the third step, in vitro analysis was performed. ECIS and wound healing and migration assay were used to evaluate the effect and response of extracellular matrix on wound healing and biocompatibility.
The research results showed that most of the cells in ECM were successfully removed from the tissue by the DAPI staining method. However, we also found the DNA content of the ECM after decellularization process was greater than 50 ng/mg. In vitro experiments, whether its test of ECIS or wound healing, HaCaT cells show a significant increase in the rate of cell-electrode attachment and cell migration in higher concentrations of extracellular matrix suspension. Although the concentration of extracellular matrix suspensions was higher than collagen, due to the current collagen is quite expensive and using our extracellular matrix is an economical solution and can achieve the same effect as collagen.
Through a series of experiments, decellularized ECM has demonstrated their potential as scaffolds to induce mechanisms of wound healing. Future research should further improve the decellularization protocol to reduce the DNA level below 50 ng/mg to prevent immune response in the future animal experiment.

Keywords: Extracellular matrix, Tissue engineering, Decellularization, Biocompatibility, Regenerative medicine

Abstract I 摘要 III Acknowledgements V List of Figures X List of Abbreviations XII 1. Introduction 1 2. Literature review 5 2.1 Extracellular matrix 5 2.2 Decellularization of tissues and organs 7 2.3 Decellularization analysis 8 2.4 Description of decellularization methods 10 2.5 Introduction to Hydrogels 13 2.6 Applications of ECM-based hydrogels 15 2.7 Development of dressings 18 2.8 Electric cell-substrate impedance sensing 20 3. Materials and Methods 22 3.1 Research Design 22 3.1.1 Experimental Theory 22 3.1.2 Experimental Design 22 3.1.3 Experimental Structure and Process 24 3.2 Materials and Equipment 25 3.2.1 Materials 25 3.2.2 Materials for cell culture 26 3.2.3 Equipment 26 3.3 Preparation of extracellular matrix 28 3.3.1 Decellularization 28 3.3.2 Mill the extracted ECM 29 3.4 Analysis after extracted of ECM 30 3.4.1 Analysis of ECM decellularized 30 3.4.2 DNA assay 31 3.4.3 Analysis of chemical residues 31 3.4.3 Surface morphology observation 31 3.4.4 Collagen concentration assay 32 3.5 Suspension of extracellular matrix 35 3.6 In Vitro cell assays 36 3.6.1 Cell culture 36 3.6.2 Cell activation 36 3.6.3 Cell cryopreservation 37 3.6.4 Cell culture medium replacement 37 3.6.5 Cell subculture 37 3.6.6 Cell counts 38 3.6.7 Electric Cell-Substrate Impedance Sensing (ECIS) 39 3.6.8 Wound healing and cell migration assay 40 4. Results 42 4.1 Analysis of extracellular matrix extracted 42 4.1.1 Analysis of ECM decellularized 42 4.1.2 DNA assay 44 4.1.3 Composition and chemical residues of ECM 46 4.1.4 Surface morphology observation of SEM 48 4.1.5 Analysis of ECM collagen concentration 51 4.2 Analysis of In Vitro cell Test 53 4.2.1 Electric Cell-Substrate Impedance Sensing (ECIS) 53 4.2.2 Wound healing and cell migration assay 57 5. Discussions 61 Analysis of extracellular matrix extract 61 In Vitro cell Test 62 6. Conclusion 64 Future prospects 64 Reference 65

[1] D. M. Faulk, J. D. Wildemann, and S. F. Badylak, "Decellularization
and cell seeding of whole liver biologic scaffolds composed of
extracellular matrix," Journal of clinical and experimental
hepatology, vol. 5, no. 1, pp. 69-80, 2015.
[2] F.-M. Chen and X. Liu, "Advancing biomaterials of human origin for
tissue engineering," Progress in polymer science, vol. 53, pp. 86-
168, 2016.
[3] T. Ota, T. W. Gilbert, S. F. Badylak, D. Schwartzman, and M. A.
Zenati, "Electromechanical characterization of a tissue-engineered
myocardial patch derived from extracellular matrix," The Journal of
thoracic and cardiovascular surgery, vol. 133, no. 4, pp. 979-985,
2007.
[4] A. D. Theocharis, S. S. Skandalis, C. Gialeli, and N. K. Karamanos,
"Extracellular matrix structure," Advanced drug delivery reviews,
vol. 97, pp. 4-27, 2016.
[5] S. D. Sackett et al., "Extracellular matrix scaffold and hydrogel
derived from decellularized and delipidized human pancreas,"
Scientific reports, vol. 8, no. 1, p. 10452, 2018.
[6] M. P. Bernard, M. L. Chu, J. C. Myers, F. Ramirez, E. F. Eikenberry,
and D. J. Prockop, "Nucleotide sequences of complementary
deoxyribonucleic acids for the pro. alpha. 1 chain of human type I
procollagen. Statistical evaluation of structures that are conserved
during evolution," Biochemistry, vol. 22, no. 22, pp. 5213-5223,
1983.
[7] J. Exposito, M. D'Alessio, M. Solursh, and F. Ramirez, "Sea urchin
collagen evolutionarily homologous to vertebrate pro-alpha 2 (I)
collagen," Journal of Biological Chemistry, vol. 267, no. 22, pp.
15559-15562, 1992.
[8] M. P. Bernard, J. C. Myers, M. L. Chu, F. Ramirez, E. F. Eikenberry,
and D. J. Prockop, "Structure of a cDNA for the pro. alpha. 2 chain
of human type I procollagen. Comparison with chick cDNA for pro.
alpha. 2 (I) identifies structurally conserved features of the protein
and the gene," Biochemistry, vol. 22, no. 5, pp. 1139-1145, 1983.
[9] T. W. Gilbert, T. L. Sellaro, and S. F. Badylak, "Decellularization of
tissues and organs," Biomaterials, vol. 27, no. 19, pp. 3675-3683,
2006.
[10] M. T. Spang and K. L. Christman, "Extracellular matrix hydrogel
therapies: in vivo applications and development," Acta
biomaterialia, vol. 68, pp. 1-14, 2018.
[11] D. O. Freytes, J. Martin, S. S. Velankar, A. S. Lee, and S. F. Badylak,
"Preparation and rheological characterization of a gel form of the
porcine urinary bladder matrix," Biomaterials, vol. 29, no. 11, pp.
1630-1637, 2008.
[12] K. Varaprasad, G. M. Raghavendra, T. Jayaramudu, M. M. Yallapu,
and R. Sadiku, "A mini review on hydrogels classification and recent
developments in miscellaneous applications," Materials Science and
Engineering: C, vol. 79, pp. 958-971, 2017.
[13] J. A. Claudio-Rizo, J. Delgado, I. A. Quintero-Ortega, J. L. MataMata, and B. Mendoza-Novelo, "Decellularized ECM-Derived
Hydrogels: Modification and Properties," Hydrogels, p. 1, 2018.
[14] L. T. Saldin, M. C. Cramer, S. S. Velankar, L. J. White, and S. F.
Badylak, "Extracellular matrix hydrogels from decellularized tissues:
structure and function," Acta biomaterialia, vol. 49, pp. 1-15, 2017.
[15] R. P. Mecham, "Overview of extracellular matrix," Current protocols
in cell biology, no. 1, pp. 10.1. 1-10.1. 14, 1998.
[16] L. Schaefer and R. M. Schaefer, "Proteoglycans: from structural
compounds to signaling molecules," Cell and tissue research, vol.
339, no. 1, p. 237, 2010.
[17] C. Frantz, K. M. Stewart, and V. M. Weaver, "The extracellular
matrix at a glance," J Cell Sci, vol. 123, no. 24, pp. 4195-4200, 2010.
[18] R. O. Hynes, "The evolution of metazoan extracellular matrix," J
Cell Biol, vol. 196, no. 6, pp. 671-679, 2012.
[19] M. W. Tibbitt and K. S. Anseth, "Hydrogels as extracellular matrix
mimics for 3D cell culture," Biotechnology and bioengineering, vol.
103, no. 4, pp. 655-663, 2009.
[20] Z. Xu, A. Ozcelikkale, Y. L. Kim, and B. Han, "Spatiotemporal
characterization of extracellular matrix microstructures in engineered
tissue: a whole-field spectroscopic imaging approach," Journal of
nanotechnology in engineering and medicine, vol. 4, no. 1, p.
011003, 2013.
[21] J. K. Kular, S. Basu, and R. I. Sharma, "The extracellular matrix:
structure, composition, age-related differences, tools for analysis and
applications for tissue engineering," Journal of tissue engineering,
vol. 5, p. 2041731414557112, 2014.
[22] J. M. Wainwright et al., "Preparation of cardiac extracellular matrix
from an intact porcine heart," Tissue Engineering Part C: Methods,
vol. 16, no. 3, pp. 525-532, 2009.
[23] T. W. Gilbert, A. M. Stewart-Akers, A. Simmons-Byrd, and S. F.
Badylak, "Degradation and remodeling of small intestinal submucosa
in canine Achilles tendon repair," JBJS, vol. 89, no. 3, pp. 621-630,
2007.
[24] P. M. Crapo, T. W. Gilbert, and S. F. Badylak, "An overview of tissue
and whole organ decellularization processes," Biomaterials, vol. 32,
no. 12, pp. 3233-3243, 2011.
[25] T. J. Keane, R. Londono, N. J. Turner, and S. F. Badylak,
"Consequences of ineffective decellularization of biologic scaffolds
on the host response," Biomaterials, vol. 33, no. 6, pp. 1771-1781,
2012.
[26] T. W. Gilbert, "Strategies for tissue and organ decellularization,"
Journal of cellular biochemistry, vol. 113, no. 7, pp. 2217-2222,
2012.
[27] M. H. Zheng, J. Chen, Y. Kirilak, C. Willers, J. Xu, and D. Wood,
"Porcine small intestine submucosa (SIS) is not an acellular
collagenous matrix and contains porcine DNA: possible implications
in human implantation," Journal of Biomedical Materials Research
Part B: Applied Biomaterials: An Official Journal of The Society for
Biomaterials, The Japanese Society for Biomaterials, and The
Australian Society for Biomaterials and the Korean Society for
Biomaterials, vol. 73, no. 1, pp. 61-67, 2005.
[28] B. N. Brown, J. E. Valentin, A. M. Stewart-Akers, G. P. McCabe, and
S. F. Badylak, "Macrophage phenotype and remodeling outcomes in
response to biologic scaffolds with and without a cellular
component," Biomaterials, vol. 30, no. 8, pp. 1482-1491, 2009.
[29] X. Dong et al., "RGD-modified acellular bovine pericardium as a
bioprosthetic scaffold for tissue engineering," Journal of Materials
Science: Materials in Medicine, vol. 20, no. 11, p. 2327, 2009.
[30] F. Bolland et al., "Development and characterisation of a full
thickness acellular porcine bladder matrix for tissue engineering,"
Biomaterials, vol. 28, no. 6, pp. 1061-1070, 2007.
[31] D. W. Courtman, C. A. Pereira, V. Kashef, D. McComb, J. M. Lee,
and G. J. Wilson, "Development of a pericardial acellular matrix
biomaterial: biochemical and mechanical effects of cell extraction,"
Journal of biomedical materials research, vol. 28, no. 6, pp. 655-
666, 1994.
[32] R. Grauss, M. Hazekamp, S. Van Vliet, A. Gittenberger-de Groot,
and M. DeRuiter, "Decellularization of rat aortic valve allografts
reduces leaflet destruction and extracellular matrix remodeling," The
Journal of thoracic and cardiovascular surgery, vol. 126, no. 6,
2003.
[33] N. T. Remlinger et al., "Hydrated xenogeneic decellularized tracheal
matrix as a scaffold for tracheal reconstruction," Biomaterials, vol.
31, no. 13, pp. 3520-3526, 2010.
[34] S. Guo, X. Ren, B. Wu, and T. Jiang, "Preparation of the acellular
scaffold of the spinal cord and the study of biocompatibility," Spinal
cord, vol. 48, no. 7, p. 576, 2010.
[35] E. K. Merritt, D. W. Hammers, M. Tierney, L. J. Suggs, T. J. Walters,
and R. P. Farrar, "Functional assessment of skeletal muscle
regeneration utilizing homologous extracellular matrix as
scaffolding," Tissue Engineering Part A, vol. 16, no. 4, pp. 1395-
1405, 2010.
[36] T. W. Hudson et al., "Optimized acellular nerve graft is
immunologically tolerated and supports regeneration," Tissue
engineering, vol. 10, no. 11-12, pp. 1641-1651, 2004.
[37] J. A. DeQuach et al., "Simple and high yielding method for
preparing tissue specific extracellular matrix coatings for cell
culture," PloS one, vol. 5, no. 9, p. e13039, 2010.
[38] L. Gui, S. A. Chan, C. K. Breuer, and L. E. Niklason, "Novel
utilization of serum in tissue decellularization," Tissue Engineering
Part C: Methods, vol. 16, no. 2, pp. 173-184, 2009.
[39] L. Du, X. Wu, K. Pang, and Y. Yang, "Histological evaluation and
biomechanical characterisation of an acellular porcine cornea
scaffold," British journal of ophthalmology, vol. 95, no. 3, pp. 410-
414, 2011.
[40] C. Deeken et al., "Method of preparing a decellularized porcine
tendon using tributyl phosphate," Journal of Biomedical Materials
Research Part B: Applied Biomaterials, vol. 96, no. 2, pp. 199-206,
2011.
[41] T. Woods and P. F. Gratzer, "Effectiveness of three extraction
techniques in the development of a decellularized bone–anterior
cruciate ligament–bone graft," Biomaterials, vol. 26, no. 35, pp.
7339-7349, 2005.
[42] S. L. Dahl, J. Koh, V. Prabhakar, and L. E. Niklason, "Decellularized
native and engineered arterial scaffolds for transplantation," Cell
transplantation, vol. 12, no. 6, pp. 659-666, 2003.
[43] G. Goissis, S. Suzigan, D. R. Parreira, J. V. Maniglia, D. M. Braile,
and S. Raymundo, "Preparation and characterization of collagen‐
elastin matrices from blood vessels intended as small diameter
vascular grafts," Artificial organs, vol. 24, no. 3, pp. 217-223, 2000.
[44] P. S. McFetridge, J. W. Daniel, T. Bodamyali, M. Horrocks, and J. B.
Chaudhuri, "Preparation of porcine carotid arteries for vascular
tissue engineering applications," Journal of Biomedical Materials
Research Part A: An Official Journal of The Society for
Biomaterials, The Japanese Society for Biomaterials, and The
Australian Society for Biomaterials and the Korean Society for
Biomaterials, vol. 70, no. 2, pp. 224-234, 2004.
[45] P. Gamba, M. Conconi, R. L. Piccolo, G. Zara, R. Spinazzi, and P.
Parnigotto, "Experimental abdominal wall defect repaired with
acellular matrix," Pediatric surgery international, vol. 18, no. 5-6,
pp. 327-331, 2002.
[46] B. N. Brown et al., "Comparison of three methods for the derivation
of a biologic scaffold composed of adipose tissue extracellular
matrix," Tissue Engineering Part C: Methods, vol. 17, no. 4, pp. 411-
421, 2011.
[47] M. Yang, C. Z. Chen, X. N. Wang, Y. B. Zhu, and Y. J. Gu,
"Favorable effects of the detergent and enzyme extraction method for
preparing decellularized bovine pericardium scaffold for tissue
engineered heart valves," Journal of Biomedical Materials Research
Part B: Applied Biomaterials, vol. 91, no. 1, pp. 354-361, 2009.
[48] T. L. Sellaro et al., "Maintenance of human hepatocyte function in
vitro by liver-derived extracellular matrix gels," Tissue Engineering
Part A, vol. 16, no. 3, pp. 1075-1082, 2009.
[49] A. P. Price, K. A. England, A. M. Matson, B. R. Blazar, and A.
Panoskaltsis-Mortari, "Development of a decellularized lung
bioreactor system for bioengineering the lung: the matrix reloaded,"
Tissue engineering Part A, vol. 16, no. 8, pp. 2581-2591, 2010.
[50] P. W. Henderson et al., "Development of an acellular bioengineered
matrix with a dominant vascular pedicle," Journal of Surgical
Research, vol. 164, no. 1, pp. 1-5, 2010.
[51] Y. Hashimoto et al., "Preparation and characterization of
decellularized cornea using high-hydrostatic pressurization for
corneal tissue engineering," Biomaterials, vol. 31, no. 14, pp. 3941-
3948, 2010.
[52] A. Hopkinson et al., "Optimization of amniotic membrane (AM)
denuding for tissue engineering," Tissue Engineering Part C:
Methods, vol. 14, no. 4, pp. 371-381, 2008.
[53] R.-N. Chen, H.-O. Ho, Y.-T. Tsai, and M.-T. Sheu, "Process
development of an acellular dermal matrix (ADM) for biomedical
applications," Biomaterials, vol. 25, no. 13, pp. 2679-2686, 2004.
[54] P. Lin, W. C. Chan, S. F. Badylak, and S. N. Bhatia, "Assessing
porcine liver-derived biomatrix for hepatic tissue engineering,"
Tissue engineering, vol. 10, no. 7-8, pp. 1046-1053, 2004.
[55] D. O. Freytes, S. F. Badylak, T. J. Webster, L. A. Geddes, and A. E.
Rundell, "Biaxial strength of multilaminated extracellular matrix
scaffolds," Biomaterials, vol. 25, no. 12, pp. 2353-2361, 2004.
[56] E. J. Lehr et al., "Decellularization reduces immunogenicity of sheep
pulmonary artery vascular patches," The Journal of thoracic and
cardiovascular surgery, vol. 141, no. 4, pp. 1056-1062, 2011.
[57] D. Jackson, E. Grood, S. Arnoczky, D. Butler, and T. Simon, "Freeze
dried anterior cruciate ligament allografts: Preliminary studies in a
goat model," The American journal of sports medicine, vol. 15, no.
4, pp. 295-303, 1987.
[58] M. B. Sano, R. E. Neal, P. A. Garcia, D. Gerber, J. Robertson, and R.
V. Davalos, "Towards the creation of decellularized organ constructs
using irreversible electroporation and active mechanical perfusion,"
Biomedical engineering online, vol. 9, no. 1, p. 83, 2010.
[59] M. Phillips, E. Maor, and B. Rubinsky, "Nonthermal irreversible
electroporation for tissue decellularization," Journal of
biomechanical engineering, vol. 132, no. 9, p. 091003, 2010.
[60] H.-R. Lin, M.-H. Ling, and Y.-J. Lin, "High strength and low friction
of a PAA-alginate-silica hydrogel as potential material for artificial
soft tissues," Journal of Biomaterials Science, Polymer Edition, vol.
20, no. 5-6, pp. 637-652, 2009.
[61] M. Bahram, N. Mohseni, and M. Moghtader, "An introduction to
hydrogels and some recent applications," in Emerging concepts in
analysis and applications of hydrogels: IntechOpen, 2016.
[62] A. K. A. Silva, C. Richard, M. Bessodes, D. Scherman, and O.-W.
Merten, "Growth factor delivery approaches in hydrogels,"
Biomacromolecules, vol. 10, no. 1, pp. 9-18, 2008.
[63] A. S. Hoffman, "Hydrogels for biomedical applications," Advanced
drug delivery reviews, vol. 64, pp. 18-23, 2012.
[64] P. Matricardi, C. Di Meo, T. Coviello, W. E. Hennink, and F.
Alhaique, "Interpenetrating polymer networks polysaccharide
hydrogels for drug delivery and tissue engineering," Advanced Drug
Delivery Reviews, vol. 65, no. 9, pp. 1172-1187, 2013.
[65] J. Li and D. J. Mooney, "Designing hydrogels for controlled drug
delivery," Nature Reviews Materials, vol. 1, no. 12, p. 16071, 2016.
[66] A. Vashist, A. Vashist, Y. Gupta, and S. Ahmad, "Recent advances in
hydrogel based drug delivery systems for the human body," Journal
of Materials Chemistry B, vol. 2, no. 2, pp. 147-166, 2014.
[67] C. Ghobril and M. Grinstaff, "The chemistry and engineering of
polymeric hydrogel adhesives for wound closure: a tutorial,"
Chemical Society Reviews, vol. 44, no. 7, pp. 1820-1835, 2015.
[68] Q. V. Nguyen, J. H. Park, and D. S. Lee, "Injectable polymeric
hydrogels for the delivery of therapeutic agents: A review," European
Polymer Journal, vol. 72, pp. 602-619, 2015.
[69] N. A. Peppas and D. S. Van Blarcom, "Hydrogel-based biosensors
and sensing devices for drug delivery," Journal of Controlled
Release, vol. 240, pp. 142-150, 2016.
[70] L. Li, Y. Shi, L. Pan, Y. Shi, and G. Yu, "Rational design and
applications of conducting polymer hydrogels as electrochemical
biosensors," Journal of Materials Chemistry B, vol. 3, no. 15, pp.
2920-2930, 2015.
[71] N. Annabi et al., "25th anniversary article: Rational design and
applications of hydrogels in regenerative medicine," Advanced
materials, vol. 26, no. 1, pp. 85-124, 2014.
[72] A. K. Gaharwar, N. A. Peppas, and A. Khademhosseini,
"Nanocomposite hydrogels for biomedical applications,"
Biotechnology and bioengineering, vol. 111, no. 3, pp. 441-453,
2014.
[73] Y. Liu, W. He, Z. Zhang, and B. P. Lee, "Recent developments in
tough hydrogels for biomedical applications," Gels, vol. 4, no. 2, p.
46, 2018.
[74] T. Ren, Y. van der Merwe, and M. B. Steketee, "Developing
extracellular matrix technology to treat retinal or optic nerve injury,"
eNeuro, vol. 2, no. 5, 2015.
[75] D. M. Faulk et al., "ECM hydrogel coating mitigates the chronic
inflammatory response to polypropylene mesh," Biomaterials, vol.
35, no. 30, pp. 8585-8595, 2014.
[76] M. T. Wolf et al., "Macrophage polarization in response to ECM
coated polypropylene mesh," Biomaterials, vol. 35, no. 25, pp. 6838-
6849, 2014.
[77] J. S. Lee et al., "Liver extracellular matrix providing dual functions
of two-dimensional substrate coating and three-dimensional
injectable hydrogel platform for liver tissue engineering,"
Biomacromolecules, vol. 15, no. 1, pp. 206-218, 2013.
[78] G. J. Chiou, C. Crowe, R. McGoldrick, K. Hui, H. Pham, and J.
Chang, "Optimization of an injectable tendon hydrogel: the effects of
platelet-rich plasma and adipose-derived stem cells on tendon
healing in vivo," Tissue Engineering Part A, vol. 21, no. 9-10, pp.
1579-1586, 2015.
[79] X. Yuan et al., "Stem cell delivery in tissue-specific hydrogel
enabled meniscal repair in an orthotopic rat model," Biomaterials,
vol. 132, pp. 59-71, 2017.
[80] D. Gothard et al., "In vivo assessment of bone regeneration in
alginate/bone ECM hydrogels with incorporated skeletal stem cells
and single growth factors," PloS one, vol. 10, no. 12, p. e0145080,
2015.
[81] S. B. Seif-Naraghi, D. Horn, P. J. Schup-Magoffin, and K. L.
Christman, "Injectable extracellular matrix derived hydrogel
provides a platform for enhanced retention and delivery of a heparinbinding growth factor," Acta biomaterialia, vol. 8, no. 10, pp. 3695-
3703, 2012.
[82] S. B. Sonnenberg et al., "Delivery of an engineered HGF fragment in
an extracellular matrix-derived hydrogel prevents negative LV
remodeling post-myocardial infarction," Biomaterials, vol. 45, pp.
56-63, 2015.
[83] E. Smith et al., "Evaluation of skeletal tissue repair, part 1:
assessment of novel growth-factor-releasing hydrogels in an ex vivo
chick femur defect model," Acta biomaterialia, vol. 10, no. 10, pp.
4186-4196, 2014.
[84] E. Bible et al., "Non-invasive imaging of transplanted human neural
stem cells and ECM scaffold remodeling in the stroke-damaged rat
brain by 19F-and diffusion-MRI," Biomaterials, vol. 33, no. 10, pp.
2858-2871, 2012.
[85] F. Pati et al., "Printing three-dimensional tissue analogues with
decellularized extracellular matrix bioink," Nature communications,
vol. 5, p. 3935, 2014.
[86] R. B. Vernon, M. D. Gooden, S. L. Lara, and T. N. Wight, "Native
fibrillar collagen membranes of micron-scale and submicron
thicknesses for cell support and perfusion," Biomaterials, vol. 26, no.
10, pp. 1109-1117, 2005.
[87] R. J. Morin and N. L. Tomaselli, "Interactive dressings and topical
agents," Clinics in plastic surgery, vol. 34, no. 4, pp. 643-658, 2007.
[88] L. I. Moura, A. M. Dias, E. Carvalho, and H. C. de Sousa, "Recent
advances on the development of wound dressings for diabetic foot
ulcer treatment—a review," Acta biomaterialia, vol. 9, no. 7, pp.
7093-7114, 2013.
[89] J. Lei et al., "The Wound Dressings and Their Applications in Wound
Healing and Management," Health Science Journal, vol. 13, no. 4,
pp. 1-8, 2019.
[90] R. S. Kirsner and W. H. Eaglstein, "The wound healing process,"
Dermatologic clinics, vol. 11, no. 4, pp. 629-640, 1993.
[91] S. Dhivya, V. V. Padma, and E. Santhini, "Wound dressings–a
review," BioMedicine, vol. 5, no. 4, 2015.
[92] J. S. Boateng, K. H. Matthews, H. N. Stevens, and G. M. Eccleston,
"Wound healing dressings and drug delivery systems: a review,"
Journal of pharmaceutical sciences, vol. 97, no. 8, pp. 2892-2923,
2008.
[93] B. A. Aderibigbe and B. Buyana, "Alginate in wound dressings,"
Pharmaceutics, vol. 10, no. 2, p. 42, 2018.
[94] A. D. Sezer and E. Cevher, "Biopolymers as wound healing
materials: challenges and new strategies," Biomaterials Applications
for Nanomedicine, pp. 383-414, 2011.
[95] P. Zahedi, I. Rezaeian, S. O. Ranaei‐Siadat, S. H. Jafari, and P.
Supaphol, "A review on wound dressings with an emphasis on
electrospun nanofibrous polymeric bandages," Polymers for
Advanced Technologies, vol. 21, no. 2, pp. 77-95, 2010.
[96] L. L. Bolton, C. L. Johnson, and L. Van Rijswijk, "Occlusive
dressings: therapeutic agents and effects on drug delivery," Clinics in
dermatology, vol. 9, no. 4, pp. 573-583, 1991.
[97] I. Giaever and C. R. Keese, "Monitoring fibroblast behavior in tissue
culture with an applied electric field," Proceedings of the National
Academy of Sciences, vol. 81, no. 12, pp. 3761-3764, 1984.
[98] I. Giaever and C. R. Keese, "A morphological biosensor for
mammalian cells," Nature, vol. 366, no. 6455, pp. 591-592, 1993.
[99] C. Renken, C. Keese, and I. Giaever, "Automated assays for
quantifying cell migration," BioTechniques, vol. 49, no. 5, p. 844,
2010.
[100] Y. Hong et al., "Mechanical properties and in vivo behavior of a
biodegradable synthetic polymer microfiber–extracellular matrix
hydrogel biohybrid scaffold," Biomaterials, vol. 32, no. 13, pp.
3387-3394, 2011.
[101] R. Noreen, M. Moenner, Y. Hwu, and C. Petibois, "FTIR spectroimaging of collagens for characterization and grading of gliomas,"
Biotechnology advances, vol. 30, no. 6, pp. 1432-1446, 2012.
[102] S. Badylak, K. Kokini, B. Tullius, A. Simmons-Byrd, and R. Morff,
"Morphologic study of small intestinal submucosa as a body wall
repair device," Journal of surgical research, vol. 103, no. 2, pp. 190-
202, 2002.

無法下載圖示 全文公開日期 2025/02/07 (校內網路)
全文公開日期 本全文未授權公開 (校外網路)
全文公開日期 本全文未授權公開 (國家圖書館:臺灣博碩士論文系統)
QR CODE